Logo Prima Biomed


Welcome to the Newsroom

22 December 2015

Prima BioMed initiates Phase IIB study in Metastatic breast cancer


ENGLISH


Prima BioMed initiates Phase IIB study in Metastatic breast cancer
      
 -  Institutional Review Board approval now obtained at four clinical sites in Belgium and three sites in the Netherlands
 -  First clinical site initiated in Belgium, University Hospital Saint-Luc in Brussels
 -  First patient expected to be dosed in early 2016 


(...)